# Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.

> **NCT06882564** · PHASE3 · RECRUITING · sponsor: **Al-Mustansiriyah University** · enrollment: 54 (estimated)

## Conditions studied

- Halitosis
- Mouth Disease
- Plaque Induced Gingival Disease
- Bleeding Gum
- Peridontal Disease

## Interventions

- **DRUG:** resveratrol mouthwash
- **DRUG:** Chlorhexidine mouthwash (0.2%)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06882564
- **Lead sponsor:** Al-Mustansiriyah University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-05
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06882564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06882564, "Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06882564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*